Cardinal Health's growth faces challenges from tariff risks, regulatory uncertainties, and competitive pressures. Learn more on CAH stock here.

(Reuters) -Drug distributor Cardinal Health raised annual adjusted profit forecast on Thursday, banking on resilient demand ...

Cardinal Health, Inc. (NYSE:CAH), a key player in the healthcare services sector, operates within a framework influenced by ...

BofA's Lutz raised Cardinal Health's target to $170, citing specialty growth momentum and a shrinking scale gap as key upside ...

A high-level overview of Cardinal Health, Inc. (CAH) stock. View (CAH) real-time stock price, chart, news, analysis, analyst reviews and more.

Cardinal Health Inc. CAH is well-poised for growth, ... manufacturer and specialty services, and nuclear and pharmacy services, which are expected to majorly drive the quarters ahead.

Cardinal Health raised its fiscal 2025 adjusted profit forecast on Friday as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit, sending shares ...

Valued at a market cap of $31.7 billion, Dublin, Ohio-based Cardinal Health, Inc. (CAH) is one of the largest U.S. pharmaceutical distributors and a leading nuclear pharmacy provider. It operates ...

Summary ・The Barchart Brief: Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to the healthcare company Cardinal Health (CAH) .

Cardinal Health Inc. CAH is well-poised for growth, ... manufacturer and specialty services, and nuclear and pharmacy services, which are expected to majorly drive the quarters ahead.